Dry eye symptoms and impact on vision-related function across International Task Force guidelines severity levels in the United States-Reference-Cited by-同舟云学术

Dry eye symptoms and impact on vision-related function across International Task Force guidelines severity levels in the United States

Published:2018-09-29 Issue:1 Volume:18 Page:
ISSN:1471-2415
Container-title:BMC Ophthalmology
language:en
Short-container-title:BMC Ophthalmol

Author:

Barber Laurie,Khodai Omid,Croley Thomas,Lievens Christopher,Montaquila Stephen,Ziemanski Jillian,McCart Melissa,Lunacsek Orsolya,Burk Caroline,Patel Vaishali

Funder

Allergan

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12886-018-0919-7.pdf

Reference43 articles.

1. Craig JP, Nichols KK, Akpek EK, Caffrey B, Dua HS, Joo C-K, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276-3.

2. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264–8.

3. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–26.

4. Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS 2 Epidemiology Report. Ocular Surface. 2017;15:334-365.

5. Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res. 2013;117:28–38.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review;International Journal of Biological Macromolecules;2023-07

2. Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis;Frontiers in Medicine;2023-04-20

3. A Microfluidic Contact Lens to Address Contact Lens‐Induced Dry Eye;Small;2022-12-23

4. A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1);The Ocular Surface;2022-10

5. A clinical decision support system for diagnosing and determining severity of dry eye disease;Eye;2022-08-22